BioCentury
ARTICLE | Clinical News

Lybrel levonorgestrel/estradiol regulatory update

May 28, 2007 7:00 AM UTC

FDA approved Lybrel, an oral low-dose combination of levonorgestrel and ethinyl estradiol as a continuous contraceptive to prevent pregnancy. WYE plans to launch Lybrel, which is taken 365 days a year...